The University of Chicago Header Logo

Connection

Michael Bishop to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications Michael Bishop has written about Recombinant Fusion Proteins.
Michael Bishop
Connection Strength
0.023
Recombinant Fusion Proteins
  1. Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013 Dec 12; 122(25):4129-39.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.